+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Therapeutics and Supportive Care Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4829816
  • Report
  • Region: Global
  • 144 pages
  • 360iResearch
1 of 3

FEATURED COMPANIES

  • Acacia Pharma Group Plc
  • Amgen Inc.
  • Aphios Corporation
  • Baxter International Inc.
  • Fagron Group B.V.
  • Helsinn Healthcare SA
  • MORE
The Global Cancer Therapeutics and Supportive Care Drugs Market is expected to grow from USD 192678.56 Millions in 2018 to USD 370896.23 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.80%.

Increasing prevalence of cancerous patients is one of the factors largely attributing to the growth of the Global Cancer Therapeutics and Supportive Care Drugs Market

The factors attributing to the growth of the market are Innovations in the development of new drugs and therapies, Growing demand for non-invasive therapies, and Increasing prevalence of cancerous patients. However, some factors such as High cost of cancer drugs may hinder the market growth. The Global Cancer Therapeutics and Supportive Care Drugs Market is expected to showcase the opportunities such as Ongoing innovations for the treatment of cancer and Clinical trials and developments of biosimilars and biologics. In the near future market may face the possible challenges in the growth due to Limited reimbursement options. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Global Cancer Therapeutics and Supportive Care Drugs Market.

On the basis of Drug Class, the Global Cancer Therapeutics and Supportive Care Drugs Market is studied across Antiemetics, Bisphosphonates, Erythropoietin-Stimulating Agents, Granulocyte-Colony Stimulating Factors, Nonsteroidal Anti-Inflammatory Drugs, and Opioids.

On the basis of Cancer Type, the Global Cancer Therapeutics and Supportive Care Drugs Market is studied across Breast Cancer, Lung Cancer, Melanoma, and Prostate Cancer.

Aphios Corporation the potential growing player for the Global Cancer Therapeutics and Supportive Care Drugs Market

The key players profiled in the Global Cancer Therapeutics and Supportive Care Drugs Market are Aphios Corporation, Heron Therapeutics, Inc., Helsinn Healthcare SA, APR Applied Pharma Research s.a., Kyowa Hakko Kirin Co., Ltd., Teva Pharmaceutical Industries Ltd., Tesaro,Inc, Baxter International Inc., Amgen Inc., Fagron Group B.V., Roche Holding AG, Acacia Pharma Group Plc, Novartis International AG (Sandoz), Johnson & Johnson, and Merck & Co..

The report covers two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model
derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Cancer Therapeutics and Supportive Care Drugs Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Cancer Therapeutics and Supportive Care Drugs Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Cancer Therapeutics and Supportive Care Drugs Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Cancer Therapeutics and Supportive Care Drugs Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Cancer Therapeutics and Supportive Care Drugs Market

The report answers questions such as:

1. What is the market size of Cancer Therapeutics and Supportive Care Drugs market in the Global?
2. What are the factors that affect the growth in the Global Cancer Therapeutics and Supportive Care Drugs Market over the forecast period?
3. What is the competitive position in the Global Cancer Therapeutics and Supportive Care Drugs Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Cancer Therapeutics and Supportive Care Drugs Market?
5. What are the opportunities in the Global Cancer Therapeutics and Supportive Care Drugs Market?
6. What are the modes of entering the Global Cancer Therapeutics and Supportive Care Drugs Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acacia Pharma Group Plc
  • Amgen Inc.
  • Aphios Corporation
  • Baxter International Inc.
  • Fagron Group B.V.
  • Helsinn Healthcare SA
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Cancer Therapeutics and Supportive Care Drugs Market
3.2. Opportunities in the Cancer Therapeutics and Supportive Care Drugs Market
3.3. Geographical Analysis in the Cancer Therapeutics and Supportive Care Drugs Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing prevalence of cancerous patients
4.2.1.2. Innovations in the development of new drugs and therapies
4.2.1.3. Growing demand for non-invasive therapies
4.2.2. Restraints
4.2.2.1. High cost of cancer drugs
4.2.3. Opportunities
4.2.3.1. Ongoing innovations for the treatment of cancer
4.2.3.2. Clinical trials and developments of biosimilars and biologics
4.2.4. Challenges
4.2.4.1. Limited reimbursement options
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Cancer Therapeutics and Supportive Care Drugs Market, by Drug Class
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Antiemetics
5.4. Bisphosphonates
5.5. Erythropoietin-Stimulating Agents
5.6. Granulocyte-Colony Stimulating Factors
5.7. Nonsteroidal Anti-Inflammatory Drugs
5.8. Opioids

6. Global Cancer Therapeutics and Supportive Care Drugs Market, by Cancer Type
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Breast Cancer
6.4. Lung Cancer
6.5. Melanoma
6.6. Prostate Cancer

7. Americas Cancer Therapeutics and Supportive Care Drugs Market Estimates & Trend Analysis
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Canada
7.4. Mexico
7.5. United States

8. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. China
8.4. India
8.5. Japan

9. Europe, Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. France
9.4. Germany
9.5. United Kingdom

10. Competitive Landscape
10.1. FPNV Positioning Matrix for Global Cancer Therapeutics and Supportive Care Drugs Market
10.2. Market Vendor Ranking Analysis for Global Cancer Therapeutics and Supportive Care Drugs Market
10.3. Competitive News Feed Analysis for Global Cancer Therapeutics and Supportive Care Drugs Market
10.3.1. Mergers & Acquisitions
10.3.2. New Product Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Agreements & Collaborations

11. Company Usability Profiles
11.1. Amgen Inc.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.1.4. Scorecard
11.2. Helsinn Healthcare SA
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.2.4. Scorecard
11.3. Heron Therapeutics, Inc.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.3.4. Scorecard
11.4. Johnson & Johnson
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.4.4. Scorecard
11.5. Merck & Co.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.5.4. Scorecard
11.6. Acacia Pharma Group Plc
11.6.1. Overview
11.6.2. Strategy
11.6.3. SWOT
11.6.4. Scorecard
11.7. Aphios Corporation
11.7.1. Overview
11.7.2. Strategy
11.7.3. SWOT
11.7.4. Scorecard
11.8. APR Applied Pharma Research s.a.
11.8.1. Overview
11.8.2. Strategy
11.8.3. SWOT
11.8.4. Scorecard
11.9. Baxter International Inc.
11.9.1. Overview
11.9.2. Strategy
11.9.3. SWOT
11.9.4. Scorecard
11.10. Fagron Group B.V.
11.10.1. Overview
11.10.2. Strategy
11.10.3. SWOT
11.10.4. Scorecard
11.11. Kyowa Hakko Kirin Co., Ltd.
11.11.1. Overview
11.11.2. Strategy
11.11.3. SWOT
11.11.4. Scorecard
11.12. Novartis International AG (Sandoz)
11.12.1. Overview
11.12.2. Strategy
11.12.3. SWOT
11.12.4. Scorecard
11.13. Roche Holding AG
11.13.1. Overview
11.13.2. Strategy
11.13.3. SWOT
11.13.4. Scorecard
11.14. Tesaro,Inc
11.14.1. Overview
11.14.2. Strategy
11.14.3. SWOT
11.14.4. Scorecard
11.15. Teva Pharmaceutical Industries Ltd.
11.15.1. Overview
11.15.2. Strategy
11.15.3. SWOT
11.15.4. Scorecard

12. Appendix
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Gastrointestinal Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Polymer Matrix Composites Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Policy Management Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global Smart Waste Management Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen Inc.
  • Helsinn Healthcare SA
  • Heron Therapeutics, Inc.
  • Johnson & Johnson
  • Merck & Co.
  • Acacia Pharma Group Plc
  • Aphios Corporation
  • APR Applied Pharma Research s.a.
  • Baxter International Inc.
  • Fagron Group B.V.
  • Kyowa Hakko Kirin Co., Ltd.
  • Novartis International AG (Sandoz)
  • Roche Holding AG
  • Tesaro,Inc
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll